Phibro Animal Health Corporation Class A (PAHC) — 分析摘要
Phibro Animal Health Corporation Class A(PAHC)的市值为1.34十亿美元,最近一年的营收同比增长了+27.4%。净利润率为3.7%。当前市盈率为14.1倍。
核心要点
- 营收同比变化+27.4%
- 净利润率3.7%
- 市盈率14.1倍
与PHARMACEUTICAL PREPARATIONS板块的其他公司相比,PAHC的营收增长为+27.4%,市盈率为14.1倍。
Phibro Animal Health Corporation Class A (PAHC)
更新 — ET · 来源 POLYGON
红旗与风险提示无重大红旗
基于最新财报,没有触发重大的信用、利润率或趋势红旗。
Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.
行业
PHARMACEUTICAL PREPARATIONS
员工人数
2,475
总部
TEANECK, NJ
Exchange
XNAS
基于 4 年财务数据的系统性竞争优势评估
此评估基于历史财务数据的量化分析,不构成投资建议。护城河评级可能随行业和竞争环境变化。
首版展示近期 SEC Forms 3、4、5 备案活动。尚未解析单笔买入/卖出交易。
资本结构
现金流
年度每股股息
$0.48
股息收益率
1.45%
股息历史
免责声明:本站内容不构成投资建议。数据来源于SEC EDGAR和Polygon.io。过往业绩不代表未来表现。投资决策前请自行研究。